Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BORTEZOMIB vs BOSENTAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BORTEZOMIB vs BOSENTAN: Safety Overview

Metric BORTEZOMIB BOSENTAN
Total FAERS Reports 47,710 19,581
Deaths Reported 7,318 4,346
Death Rate 15.3% 22.2%
Hospitalizations 14,626 8,862
Average Patient Age 64.1 yrs 52.5 yrs
% Female Patients 44.5% 73.2%
FDA Approval Date Aug 26, 2024 Apr 26, 2019
Manufacturer Hikma Pharmaceuticals USA Inc. Actelion Pharmaceuticals US, Inc.
Route INTRAVENOUS ORAL
Marketing Status Prescription Prescription